Patients with lupus and arthritis lose out following rush for chloroquine

While Chinese and French researchers have conducted studies on Covid-19 using chloroquine or hydroxychloroquine, concrete results have proven elusive. - AFP

BANGKOK (The Straits Times/ANN): It is yet unproven, but a belief that a drug commonly used to control inflammation could be a ward against the coronavirus has triggered a run on it, making it tough for patients suffering from illnesses such as lupus and arthritis to find relief.

Chronic patients such as teacher Wun Pyae Thidar, a lupus patient from Myanmar's Taungoo city, have had difficulties securing supplies of the anti-malarial drug chloroquine and its derivative hydroxychloroquine.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Regional

Top Korean actor Yoo Ah-in under investigation for alleged illegal use of propofol drug
Kremlin dismisses claims Putin was involved in MH17 downing
Hussein Omar Khan to be new Selangor police chief
Thailand rolls out the red carpet for PM Anwar
Selangor polls could go either way, say analysts
Apex court denies JJ's children leave to appeal over RM1bil in shares
Man gets six years jail for committing unnatural sex on step-sister
Indonesia, Malaysia to send palm oil envoys to EU over deforestation law
1MDB trial: Jho Low was 'boss', Najib was the 'big boss', witness tells court
In a first for India, transgender couple become biological parents

Others Also Read